Back
MicroSectors™ FANG+™ 2X Leveraged ETN Vs. Corcept Therapeutics Industry Stock Comparison
Buy
82
FNGO
MicroSectors™ FANG+™ 2X Leveraged ETN
Last Price:
84.88
Seasonality Move:
33.78%
Buy
86
CORT
Corcept Therapeutics
Last Price:
57.76
Seasonality Move:
4.71%
Buy
82
MicroSectors™ FANG+™ 2X Leveraged ETN (FNGO)
is a Buy
Is MicroSectors™ FANG+™ 2X Leveraged ETN a Buy, Sell or Hold?
- The current MicroSectors™ FANG+™ 2X Leveraged ETN [FNGO] share price is $83.54. The Score for FNGO is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- FNGO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
86
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $59.12. The Score for CORT is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
FNGO Stock Price Chart
What is MicroSectors™ FANG+™ 2X Leveraged ETN's stock price today?
-
The MicroSectors™ FANG+™ 2X Leveraged ETN share price today is $83.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FNGO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $59.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
FNGO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.47 | Buy |
| Relative Strength Index (14 RSI): | 65.89 | Buy |
| Chaikin Money Flow: | 25470 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.91 - 79.95) | Buy |
| Bollinger Bands (100): | (65.65 - 78.13) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.33 | Buy |
| Relative Strength Index (14 RSI): | 78.53 | Buy |
| Chaikin Money Flow: | 99396 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.14 - 52.96) | Buy |
| Bollinger Bands (100): | (31.8 - 46.2) | Buy |
FNGO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 78.93 | Buy |
| 20-day SMA: | 77.27 | Buy |
| 50-day SMA: | 72.73 | Buy |
| 200-day SMA: | 65.57 | Buy |
| 8-day EMA: | 80.49 | Buy |
| 20-day EMA: | 77.76 | Buy |
| 50-day EMA: | 74.36 | Buy |
| 200-day EMA: | 64.74 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.25 | Buy |
| 20-day SMA: | 49.96 | Buy |
| 50-day SMA: | 44.55 | Buy |
| 200-day SMA: | 32.18 | Buy |
| 8-day EMA: | 54.41 | Buy |
| 20-day EMA: | 50.72 | Buy |
| 50-day EMA: | 45.72 | Buy |
| 200-day EMA: | 35.55 | Buy |
MicroSectors™ FANG+™ 2X Leveraged ETN Earnings Growth & FNGO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
MicroSectors™ FANG+™ 2X Leveraged ETN Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||